Timothy Cofer
Summary
Timothy Cofer is Keurig Dr Pepper’s Chief Executive Officer and a director, having joined the company in late 2023 and assumed the CEO role on April 26, 2024.
Biography
Cofer is a consumer-packaged-goods executive with roughly 35 years of multinational experience in brand building, business transformations and mergers and acquisitions. Before joining KDP, he was Chief Executive Officer of Central Garden & Pet Company, where the company reported a multiyear period of double-digit revenue and profit growth alongside strategic acquisitions. Earlier in his career, Cofer spent about 28 years at Mondelēz International and its predecessor, Kraft Foods. He held senior roles including President of Asia Pacific, Middle East and Africa at Mondelēz, President of Kraft Foods Europe, President of Kraft Pizza Company, President of Oscar Mayer Foods and Executive Vice President and Chief Growth Officer. He also helped lead the global integration of Kraft and Cadbury. Cofer holds an MBA from the University of Minnesota and bachelor’s degrees in economics and political science from St. Olaf College.
Notable achievements
- Led KDP’s acquisition of JDE Peet’s, which closed in April 2026.
- Oversaw the company’s plan to separate its coffee and beverage operations into two independent businesses.
- Helped expand KDP’s portfolio in energy and functional beverages through the GHOST acquisition.
- KDP reported that Dr Pepper became the No. 2 soda brand in the United States during his leadership.
- Advanced initiatives including data-driven marketing, a broader brand portfolio and the Keurig Alta brewing system.
Problem areas / controversies
- The JDE Peet’s acquisition increased KDP’s debt and added complexity to the planned separation; credit agencies and investors raised concerns about leverage and execution.
- KDP’s 2025 results included declines in K-Cup pod and appliance volumes, particularly in the U.S. coffee segment.
- The success of the JDE Peet’s integration and the eventual separation remains unproven and depends on significant operational execution.
- No major personal regulatory or ethics controversy involving Cofer was identified in the reviewed filings and reputable reporting.